First Quadrant’s Xylem XYL Stock Holding History

First Quadrant’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-118,160	Closed	-$5.85M	–	849
2016 Q4	$5.85M	Buy	+118,160	New	+$5.99M	0.12%	228
2016 Q2	–	Sell	-281,800	Closed	-$11.5M	–	852
2016 Q1	$11.5M	Buy	+281,800	New	+$10.4M	0.25%	136

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Quadrant's XYL Position: Q1 2017 in Review

First Quadrant sold out of Xylem (XYL) in Q1 2017, closing a stake of 118,160 shares — an estimated $5.85M sold.

First Quadrant first reported a position in XYL in Q1 2016 and held it in 2 quarters. The position peaked at $11.5M in Q1 2016. 546 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

First Quadrant reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
First Quadrant sold 118,160 Xylem shares in Q1 2017, an estimated $5.85M.
First Quadrant first reported a position in Xylem in Q1 2016 and held it in 2 quarters.
First Quadrant's Xylem position peaked at $11.5M in Q1 2016.
546 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on First Quadrant's 13F filing for Q1 2017, filed 25 Apr 2017.